Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Avoiding Adjuvant Prophylactic Neck Irradiation in Lateralized Oral Cavity Cancer (APRON).

Clinical oncology (Royal College of Radiologists (Great Britain))·2025

Same author

In-Hospital Mortality Among Hematological Malignancy Patients Undergoing Bronchoscopy for Suspected Invasive Pulmonary Aspergillosis: Focusing on Coinfections and Nodules on Chest CT.

Mycopathologia·2025

Same author

Working memory and the need for explainable AI - Scenarios from healthcare, social media and insurance.

Heliyon·2025

Same author

Feasibility and Cost-Effectiveness of Daycare Anterior Cruciate Ligament Reconstruction - A Retrospective Case Series.

Malaysian orthopaedic journal·2024

Same author

Acute toxicity of some expired insecticides on rats and their effects on some vital parameters and residues in the liver and kidney.

Brazilian journal of biology = Revista brasleira de biologia·2024

Same author

Flexor Hallucis Longus Transfer And V-Y Plasty: An Effective Treatment Modality for Chronic Achilles Rupture - A Case Series.

Malaysian orthopaedic journal·2023

Search research articles

Related Experiment Video

Updated: May 7, 2026

In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model

In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model

Published on: October 3, 2011

Targeted therapies and hypoxia imaging.

R Ali¹, E E Graves

¹Department of Radiation Oncology, Stanford University, Stanford, CA, USA - egraves@stanford.edu.

The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of

|September 19, 2013

Summary

Hypoxia-specific cytotoxins show promise for treating tumors, but patient selection using hypoxia imaging is crucial for treatment success. This review explores cytotoxins, imaging methods, and past studies to guide future clinical evaluations.

More Related Videos

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Published on: August 31, 2022

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

Published on: February 14, 2025

Related Experiment Videos

Last Updated: May 7, 2026

In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model

In vivo Bioluminescence Imaging of Tumor Hypoxia Dynamics of Breast Cancer Brain Metastasis in a Mouse Model

Published on: October 3, 2011

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Non-Invasive PET/MR Imaging in an Orthotopic Mouse Model of Hepatocellular Carcinoma

Published on: August 31, 2022

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

Published on: February 14, 2025

Area of Science:

Oncology
Medical Imaging
Pharmacology

Background:

Hypoxia-specific cytotoxins offer targeted cancer treatment potential.
Recent clinical trials underscore the need for predictive biomarkers.
Tumor hypoxia is a significant challenge in cancer therapy.

Purpose of the Study:

To review available hypoxia-specific cytotoxins.
To describe the application of hypoxia imaging in patient selection.
To analyze studies combining hypoxia-targeted therapies and imaging.

Main Methods:

Literature review of hypoxia-specific cytotoxins.
Analysis of hypoxia imaging techniques for predicting treatment response.
Survey of clinical and preclinical studies integrating cytotoxin therapy and imaging.

Main Results:

Identification of various hypoxia-specific cytotoxins.
Demonstration of hypoxia imaging's role in patient stratification.
Synthesis of data from combined therapy and imaging studies.

Conclusions:

Effective patient selection via hypoxia imaging is vital for successful cytotoxin therapy.
Lessons learned from prior studies can optimize future clinical trials.
Integrating imaging and targeted cytotoxins holds promise for improved cancer treatment outcomes.